A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

BACKGROUND: Local recurrence and remote metastasis are major challenges to overcome in order to improve the survival of patients with cancer after surgery. Oncolytic viruses are a particularly attractive option for prevention of postsurgical disease as they offer a non-toxic treatment option that ca...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Ahmed, Jahangir, Chard, Louisa S, Yuan, Ming, Wang, Jiwei, Howells, Anwen, Li, Yuenan, Li, Haoze, Zhang, Zhongxian, Lu, Shuangshuang, Gao, Dongling, Wang, Pengju, Chu, Yongchao, Al Yaghchi, Chadwan, Schwartz, Joel, Alusi, Ghassan, Lemoine, Nicholas, Wang, Yaohe
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206973/
https://ncbi.nlm.nih.gov/pubmed/32217766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000415
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados